A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

NCT06431594 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Neoplasms

Interventions

DRUG: GSK5733584

Sponsor

GlaxoSmithKline